In this side of the Point/Counterpoint, Drs. Kelly and Knudsen state that limitations exist for guiding therapeutic treatment with genomic testing in prostate cancer patients.
Karen E. Knudsen, PhD
Advertisement
Articles by Karen E. Knudsen, PhD
Advertisement
Latest Updated Articles
COUNTERPOINT-Prostate Cancer Genomic Analysis: Routine or Research Only?Published: December 17th 2018 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
ESMO 2025: The Top 10 Takeaways That May Shift Oncology Practice
2
FDA Approves Revumenib in R/R NPM1-Mutant AML
3
Awareness Fuels Progress: Upcoming Advances in Breast Cancer Treatment
4
FDA Approves Belantamab Mafodotin in R/R Multiple Myeloma
5
